Literature DB >> 174413

A model for the quantitative study of Arthus (immunologic) hypersensitivity in rats.

S Yamamoto, C J Dunn, D A Deporter, F Capasso, D A Willoughby, E C Huskinsson.   

Abstract

A model of reverse passive Arthus (RPA) reaction in the pleural cavity of rats is described. The time course of development of exudate and migration of cells has been examined. It has been found to be complement dependent and dominated by polymorphonuclear cells. The reaction reaches a peak around 6 hours after challenge. Cyclic AMP levels have been measured both intracellularly and extracellularly and have been found to persist at high levels after the waning of the reaction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 174413     DOI: 10.1007/bf02205246

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  Quantitative studies on cell-mediated immunity in the pleural cavity of guinea-pigs.

Authors:  S Yamamoto; C J Dunn; F Capasso; D A Deporter; D A Willoughby
Journal:  J Pathol       Date:  1975-10       Impact factor: 7.996

2.  Further studies on carrageenan-induced pleurisy in rats.

Authors:  F Capasso; C J Dunn; S Yamamoto; D A Willoughby; J P Giroud
Journal:  J Pathol       Date:  1975-06       Impact factor: 7.996

3.  Diagnostic complement fixation. I. A method.

Authors:  A G OSLER; J H STRAUSS; M M MAYER
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1952-03

4.  Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells.

Authors:  M Kaliner; K F Austen
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

6.  Distribution of prostaglandins in inflammatory exudate.

Authors:  G P Velo; C J Dunn; J P Giroud; J Timsit; D A Willoughby
Journal:  J Pathol       Date:  1973-11       Impact factor: 7.996

7.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

Authors:  M Ballow; C G Cochrane
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

8.  Use of the reversed passive Arthus reaction as a test for anti-inflammatory agents.

Authors:  M B Goldlust; W F Schreiber
Journal:  Agents Actions       Date:  1975-02

9.  A physiologic differentiation between delayed and immediate hypersensitivity.

Authors:  M A Apicella; J C Allen
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

10.  Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function.

Authors:  R B Zurier; G Weissmann; S Hoffstein; S Kammerman; H H Tai
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

  10 in total
  18 in total

1.  Protease inhibitors reduce the reverse passive Arthus reaction.

Authors:  Y G Hyman; T L Vischer
Journal:  Agents Actions       Date:  1978-10

2.  Cyclic adenosine 3', 5'-monophosphate and the mechanism of action of three common anti-inflammatory drugs.

Authors:  D A Deporter; C J Dunn; D A Willoughby
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

3.  Professor Derek Albert Willoughby (1930-2004).

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

4.  Leukotriene B4 production and pharmacologic regulation of reverse passive Arthus pleurisy: importance of antigen dose.

Authors:  B M Weichman; J W Berkenkopf; C A Cullinan; R J Sturm
Journal:  Agents Actions       Date:  1987-08

Review 5.  Immunological concepts and the eye: a review of the classical and ocular arthus reactions.

Authors:  L D Ormerod
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

6.  The role of ICAM-1 in the reverse passive Arthus reaction induced pleurisy in the rat.

Authors:  L E Fielding; S K Buckley; M Perez; D Grimes; F Bard; G Gordan; H Horner; T Yednock
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

Review 7.  The role of cAMP regulation in controlling inflammation.

Authors:  A R Moore; D A Willoughby
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

8.  Lotifazole (F 1686), a non-steroidal anti-inflammatory agent with an unusual pharmacological spectrum.

Authors:  J P Tarayre; V Caillol; M Barbara; G Villanova; M Bru; M Aliaga; H Lauressergues
Journal:  Agents Actions       Date:  1984-01

9.  Studies on mechanisms of immobilization of mononuclear cells in the delayed hypersensitivity (DH) reaction.

Authors:  S Yamamoto
Journal:  Agents Actions       Date:  1976-02

10.  Cyclic adenosine 3',5'-monophosphate and leucocyte chemotaxis in vivo.

Authors:  D A Deporter
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.